Saad Z. Usmani, MD Healthcare Professional
Levine Cancer Institute,
1021 Morehead Medical Drive, Suite 5300
Charlotte, North Carolina, United States
Saad Zafar Usmani joined Levine Cancer Institute as the Director of Plasma Cell Disorder Program and the Director of Clinical Research in Hematologic Malignancies at Levine Cancer Institute/Carolinas Healthcare System. He is a specialist in Hematology, Medical Oncology and Bone Marrow Transplantation. He also holds an academic appointment as Clinical Associate Professor of Medicine at the University of North Carolina – Chapel Hill School of Medicine. Dr. Usmani received his medical education at Allama Iqbal Medical College Lahore, Pakistan. He completed a residency in Internal Medicine at Sinai-Grace Hospital/Wayne State University in Detroit, Michigan, and a fellowship in Hematology & Oncology at the University of Connecticut Health Center in Farmington, Connecticut.
Dr. Usmani’s clinical and translational research has been focused on plasma cell disorders in general, and high-risk multiple myeloma in specific. He is a member of the International Myeloma Working Group, the SWOG Myeloma Committee, the Bone Marrow Transplant- Clinical Trials Network Myeloma Committee, the American Society of Hematology, the American Society of Clinical Oncology and the American Society of Bone Marrow Transplantation. He is also serving on the ASCO Scientific Committee on lymphoma and plasma cell disorders, and the ASH Committee on plasma cell neoplasia.